| Tumor acidity-sensitive polymeric vector for active targeted siRNA delivery CY Sun, S Shen, CF Xu, HJ Li, Y Liu, ZT Cao, XZ Yang, JX Xia, J Wang Journal of the American Chemical Society 137 (48), 15217-15224, 2015 | 319 | 2015 |
| Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation SY Li, Y Liu, CF Xu, S Shen, R Sun, XJ Du, JX Xia, YH Zhu, J Wang Journal of Controlled Release 231, 17-28, 2016 | 190 | 2016 |
| Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds TM Sun, YC Wang, F Wang, JZ Du, CQ Mao, CY Sun, RZ Tang, Y Liu, ... Biomaterials 35 (2), 836-845, 2014 | 182 | 2014 |
| An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases Y Liu, WN Crowe, L Wang, Y Lu, WJ Petty, AA Habib, D Zhao Nature communications 10 (1), 5108, 2019 | 176 | 2019 |
| Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells R Sun, Y Liu, SY Li, S Shen, XJ Du, CF Xu, ZT Cao, Y Bao, YH Zhu, YP Li, ... Biomaterials 37, 405-414, 2015 | 176 | 2015 |
| Facile generation of tumor‐pH‐labile linkage‐bridged block copolymers for chemotherapeutic delivery CY Sun, Y Liu, JZ Du, ZT Cao, CF Xu, J Wang Angewandte Chemie International Edition 55 (3), 1010-1014, 2016 | 167 | 2016 |
| Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases C Xu, Z Lu, Y Luo, Y Liu, Z Cao, S Shen, H Li, J Liu, K Chen, Z Chen, ... Nature Communications 9 (1), 4092, 2018 | 165 | 2018 |
| Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy XZ Yang, XJ Du, Y Liu, YH Zhu, YZ Liu, YP Li, J Wang Advanced materials 26 (6), 931-936, 2014 | 147 | 2014 |
| Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer … SY Li, R Sun, HX Wang, S Shen, Y Liu, XJ Du, YH Zhu, W Jun Journal of controlled release 205, 7-14, 2015 | 124 | 2015 |
| Responsive nanocarriers as an emerging platform for cascaded delivery of nucleic acids to cancer Y Liu, CF Xu, S Iqbal, XZ Yang, J Wang Advanced drug delivery reviews 115, 98-114, 2017 | 120 | 2017 |
| Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles Y Liu, YH Zhu, CQ Mao, S Dou, S Shen, ZB Tan, J Wang Journal of controlled release 192, 114-121, 2014 | 114 | 2014 |
| Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery CF Xu, HB Zhang, CY Sun, Y Liu, S Shen, XZ Yang, YH Zhu, J Wang Biomaterials 88, 48-59, 2016 | 103 | 2016 |
| Systemic delivery of CRISPR/Cas9 with PEG-PLGA nanoparticles for chronic myeloid leukemia targeted therapy Y Liu, G Zhao, CF Xu, YL Luo, ZD Lu, J Wang Biomaterials science 6 (6), 1592-1603, 2018 | 87 | 2018 |
| NIR‐Activated supersensitive drug release using nanoparticles with a flow core J Wang, Y Liu, Y Ma, C Sun, W Tao, Y Wang, X Yang, J Wang Advanced Functional Materials 26 (41), 7516-7525, 2016 | 79 | 2016 |
| Synthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA delivery CQ Mao, MH Xiong, Y Liu, S Shen, XJ Du, XZ Yang, S Dou, PZ Zhang, ... Molecular Therapy 22 (5), 964-973, 2014 | 62 | 2014 |
| Optimization of lipid-assisted nanoparticle for disturbing neutrophils-related inflammation Y Liu, ZT Cao, CF Xu, ZD Lu, YL Luo, J Wang Biomaterials 172, 92-104, 2018 | 59 | 2018 |
| Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy CF Xu, Y Liu, S Shen, YH Zhu, J Wang Biomaterials 51, 1-11, 2015 | 59 | 2015 |
| Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion Y Liu, L Wang, Q Song, M Ali, WN Crowe, GL Kucera, GA Hawkins, ... Nature nanotechnology 17 (2), 206-216, 2022 | 52 | 2022 |
| Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy S Shen, CY Sun, XJ Du, HJ Li, Y Liu, JX Xia, YH Zhu, J Wang Biomaterials 70, 71-83, 2015 | 46 | 2015 |
| Cationic lipid-assisted polymeric nanoparticle mediated GATA2 siRNA delivery for synthetic lethal therapy of KRAS mutant non-small-cell lung carcinoma S Shen, CQ Mao, XZ Yang, XJ Du, Y Liu, YH Zhu, J Wang Molecular pharmaceutics 11 (8), 2612-2622, 2014 | 43 | 2014 |
